米国企業
Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc.AMPH

時価総額

$24.1億

PER

17.5倍

	2014年 12月31日	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日
Product revenues, net	-	-	-	-	-	-	-	-	-	593
Other revenues	-	-	-	-	-	-	-	-	-	51
Total net revenues	210	252	255	240	295	322	350	438	499	644
Product revenues, net	-	-	-	-	-	-	-	-	-	593
Other revenues	-	-	-	-	-	-	-	-	-	51
Total net revenues	210	252	255	240	295	322	350	438	499	644
Cost of Revenue	159	174	151	149	188	190	207	238	250	293
Gross profit	51	77	104	91	107	132	143	200	249	351
Selling, distribution, and marketing	6	5	5	6	8	13	15	17	22	29
General and administrative	35	42	42	44	50	50	50	51	45	52
Research and development	28	37	41	43	58	69	67	61	75	74
Total operating expenses	69	84	88	92	116	132	132	130	141	154
Income from operations	-18	-7	16	-1	-9	-0	11	70	107	197
Interest income	0	0	0	0	0	1	1	1	1	5
Interest expense	1	1	1	1	0	0	0	1	2	27
Other income (expenses), net	0	-3	0	3	-2	59	-7	15	9	-4
Total non-operating income (expenses), net	-0	-3	-1	3	-1	60	-6	14	9	-26
Income before income taxes	-18	-10	15	2	-10	60	5	84	116	171
Income tax provision	-7	-8	4	-3	-3	14	4	21	23	32
Income before equity in losses of unconsolidated affiliate	-	-	-	-	-	-	-	64	93	140
Income (Loss) from Equity Method Investments	-	-	-	-	-	-	-	-0	-1	-2
Net income attributable to Amphastar Pharmaceuticals, Inc.	-	-	-	-	-7	47	1	63	91	138
Net income attributable to non-controlling interests	-	-	-	-	-1	-2	-0	1	-	-
Net income attributable to Amphastar Pharmaceuticals, Inc.	-11	-3	11	5	-6	49	1	63	91	138
Basic (in Dollars per share)	-0.25	-0.06	0.23	0.1	-0.12	1.04	0.03	1.3	1.88	2.85
Diluted (in Dollars per share)	-0.25	-0.06	0.22	0.09	-0.12	0.98	0.03	1.25	1.74	2.6
Cost of Revenue	159	174	151	149	188	190	207	238	250	293
Gross profit	51	77	104	91	107	132	143	200	249	351
Selling, distribution, and marketing	6	5	5	6	8	13	15	17	22	29
General and administrative	35	42	42	44	50	50	50	51	45	52
Research and development	28	37	41	43	58	69	67	61	75	74
Total operating expenses	69	84	88	92	116	132	132	130	141	154
Income from operations	-18	-7	16	-1	-9	-0	11	70	107	197
Interest income	0	0	0	0	0	1	1	1	1	5
Interest expense	1	1	1	1	0	0	0	1	2	27
Other income (expenses), net	0	-3	0	3	-2	59	-7	15	9	-4
Total non-operating income (expenses), net	-0	-3	-1	3	-1	60	-6	14	9	-26
Income before income taxes	-18	-10	15	2	-10	60	5	84	116	171
Income tax provision	-7	-8	4	-3	-3	14	4	21	23	32
Income before equity in losses of unconsolidated affiliate	-	-	-	-	-	-	-	64	93	140
Income (Loss) from Equity Method Investments	-	-	-	-	-	-	-	-0	-1	-2
Net income attributable to Amphastar Pharmaceuticals, Inc.	-	-	-	-	-7	47	1	63	91	138
Net income attributable to non-controlling interests	-	-	-	-	-1	-2	-0	1	-	-
Net income attributable to Amphastar Pharmaceuticals, Inc.	-11	-3	11	5	-6	49	1	63	91	138
Basic (in Dollars per share)	-0.25	-0.06	0.23	0.1	-0.12	1.04	0.03	1.3	1.88	2.85
Diluted (in Dollars per share)	-0.25	-0.06	0.22	0.09	-0.12	0.98	0.03	1.25	1.74	2.6